Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies

Abstract Background The incidence of anaphylaxis is increasing in several parts of the world; thus, determining the prevalence of the disease in a given region is important to understand the factors involved and to promote measures to avoid this type of allergic reaction. Aiming this objective, we v...

Full description

Bibliographic Details
Main Authors: Elaine Gagete, Lucilene Delazari dos Santos, Leticia Gomes de Pontes, Fábio Morato Castro
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:World Allergy Organization Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40413-017-0171-2
id doaj-fe03dd61e48a4cb58adec71dbd07cf5a
record_format Article
spelling doaj-fe03dd61e48a4cb58adec71dbd07cf5a2020-11-25T01:02:48ZengElsevierWorld Allergy Organization Journal1939-45512017-11-0110111010.1186/s40413-017-0171-2Who has anaphylaxis in Brazil? Validation of a questionnaire for population studiesElaine Gagete0Lucilene Delazari dos Santos1Leticia Gomes de Pontes2Fábio Morato Castro3Faculdade de MedicinaUniversidade de São Paulo (Medical School of University of Sao Paulo (USP)CEVAP, Universidade Estadual Paulista – Botucatu (São Paulo State University - UNESP- Botucatu)CEVAP, Universidade Estadual Paulista – Botucatu (São Paulo State University - UNESP- Botucatu)Faculdade de MedicinaUniversidade de São Paulo (Medical School of University of Sao Paulo (USP)Abstract Background The incidence of anaphylaxis is increasing in several parts of the world; thus, determining the prevalence of the disease in a given region is important to understand the factors involved and to promote measures to avoid this type of allergic reaction. Aiming this objective, we validated an instrument for a population-basedstudy that assesses the prevalence of anaphylaxis in the Brazilian population. Methods A questionnaire was generated in two variants - one for subjects seven years old or above (Group A) and another for children who were up to six years, 11 months and 29 days (Group B). The instrument was administered to patients with and without anaphylaxis. By allocating points, a score was calculated to differentiate subjects with and without the disease. After validation, the questionnaire was applied in the city of Botucatu (São Paulo state, Brazil), by randomly selecting houses and inviting residents to answer the questionnaire. Results The questionnaire was reliable for identifying subjects with and without anaphylaxis in both groups, with a specificity and sensitivity above 90%. The prevalence of anaphylaxis in the pilot survey was 6.2% in Group A, however the evaluation was compromised in Group B by the low number of children below seven years of age due to random sampling of residences. Discussion The prevalence of anaphylaxis in our pilot test (6.2%) was similar to major epidemiological surveys from several parts of the world, showing that anaphylaxis is not a rare disease. The instrument of the present work was suitable for this epidemiological survey and might be a good option for studying anaphylaxis in other populations. Conclusion This instrument might be of particular value in places where researchers cannot access medical records to conduct similar epidemiological studies.http://link.springer.com/article/10.1186/s40413-017-0171-2AnaphylaxisEpidemiologySurveys and questionnaires
collection DOAJ
language English
format Article
sources DOAJ
author Elaine Gagete
Lucilene Delazari dos Santos
Leticia Gomes de Pontes
Fábio Morato Castro
spellingShingle Elaine Gagete
Lucilene Delazari dos Santos
Leticia Gomes de Pontes
Fábio Morato Castro
Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
World Allergy Organization Journal
Anaphylaxis
Epidemiology
Surveys and questionnaires
author_facet Elaine Gagete
Lucilene Delazari dos Santos
Leticia Gomes de Pontes
Fábio Morato Castro
author_sort Elaine Gagete
title Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_short Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_full Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_fullStr Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_full_unstemmed Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_sort who has anaphylaxis in brazil? validation of a questionnaire for population studies
publisher Elsevier
series World Allergy Organization Journal
issn 1939-4551
publishDate 2017-11-01
description Abstract Background The incidence of anaphylaxis is increasing in several parts of the world; thus, determining the prevalence of the disease in a given region is important to understand the factors involved and to promote measures to avoid this type of allergic reaction. Aiming this objective, we validated an instrument for a population-basedstudy that assesses the prevalence of anaphylaxis in the Brazilian population. Methods A questionnaire was generated in two variants - one for subjects seven years old or above (Group A) and another for children who were up to six years, 11 months and 29 days (Group B). The instrument was administered to patients with and without anaphylaxis. By allocating points, a score was calculated to differentiate subjects with and without the disease. After validation, the questionnaire was applied in the city of Botucatu (São Paulo state, Brazil), by randomly selecting houses and inviting residents to answer the questionnaire. Results The questionnaire was reliable for identifying subjects with and without anaphylaxis in both groups, with a specificity and sensitivity above 90%. The prevalence of anaphylaxis in the pilot survey was 6.2% in Group A, however the evaluation was compromised in Group B by the low number of children below seven years of age due to random sampling of residences. Discussion The prevalence of anaphylaxis in our pilot test (6.2%) was similar to major epidemiological surveys from several parts of the world, showing that anaphylaxis is not a rare disease. The instrument of the present work was suitable for this epidemiological survey and might be a good option for studying anaphylaxis in other populations. Conclusion This instrument might be of particular value in places where researchers cannot access medical records to conduct similar epidemiological studies.
topic Anaphylaxis
Epidemiology
Surveys and questionnaires
url http://link.springer.com/article/10.1186/s40413-017-0171-2
work_keys_str_mv AT elainegagete whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
AT lucilenedelazaridossantos whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
AT leticiagomesdepontes whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
AT fabiomoratocastro whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
_version_ 1725203533338247168